Jonathan Block; Analyst; Stiefel Laboratories Inc Navann Ty Dietschi; Analyst; BNP Paribas Exane ...

Idexx delivered revenue and EPS growth of 6% and 13% in Q4, but its guidance appears to have caught the market's attention. Looking ahead to 2025, management expects the company to grow sales by 4 ...

IDEXX Laboratories is poised for growth in the pet healthcare market, driven by an aging pet population and strong pet-owner bonds. IDEXX's comprehensive ecosystem, including AI-driven diagnostics ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments. Idexx Laboratories offers a variety of products and diagnostic services ...

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Monday posted fourth-quarter earnings and revenue that beat market expectations and issued initial financial guidance for 2025. The Westbrook-based maker ...

Piotr Swat / SOPA Images / LightRocket via Getty Images IDEXX Laboratories exceeded earnings and revenue estimates on sales of its animal testing products and price increases. The veterinary ...

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...

IDEXX Laboratories (IDXX) was the best-performing stock in the S&P 500 after the provider of veterinary healthcare products and services beat profit and sales estimates on growing demand for its ...

BofA analyst Michael Ryskin raised the firm’s price target on Idexx Laboratories (IDXX) to $535 from $475 and keeps a Neutral rating on the shares after the company reported a “strong” Q4 ...

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of IDEXX Laboratories, Inc. IDXX rose sharply during Monday's session after the company reported ...

Real estate and technology sectors gain. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold ...

IDEXX Q4 adjusted EPS rose 10% YoY to $2.53, beating the $2.40 estimate. Revenue grew 6% to $954.3M, surpassing the $934.99M consensus. 2025 revenue guidance set at $4.055B–$4.170B vs. $4.14B ...